Roland Griffiths, Ph.D. on Psilocybin, Psychedelic Therapies & Mystical Experiences

Neurogenesis

Psilocybin's potential to stimulate neurogenesis offers promising avenues for treating PTSD. Rhonda Patrick highlights research showing psilocybin's ability to increase neurogenesis in the dentate gyrus, a brain region linked to fear extinction 1. This process involves breaking old neural connections to form new ones, potentially aiding in trauma recovery. Roland Griffiths adds that ongoing studies suggest these effects might be mediated by serotonin receptors, particularly the 2A subtype, and are likely linked to glutamate pathways 1.

Psilocybin and the classic hallucinogens do bind serotonin two A and two C. The effects are bleed from antagonism studies to be mediated primarily through two A.

--- Roland Griffiths

These findings could revolutionize our understanding of psilocybin's therapeutic potential.

   

Default Mode

Psilocybin's impact on the Default Mode Network (DMN) is akin to the effects of meditation, offering insights into ego dissolution and present-moment awareness. Roland Griffiths explains that psilocybin decreases DMN activity, which is associated with self-referential processing and rumination, often heightened in depression 2. This reduction in activity mirrors the effects seen in long-term meditators, suggesting a shared pathway in achieving a state of mindfulness.

Psilocybin looks very much like meditation in that regard. So there's decreases in the Default Mode Network and that kind of fits with this story.

--- Roland Griffiths

Understanding these changes could enhance therapeutic approaches for mental health conditions.

   

Serotonin

The role of serotonin receptors in psilocybin's effects is crucial for understanding its impact on mood and perception. Roland Griffiths notes that psilocybin primarily interacts with serotonin 2A receptors, influencing downstream pathways like glutamate, which are linked to mood regulation 1. This interaction opens up new research avenues, particularly in treating anxiety and depression in cancer patients, where traditional therapies often fall short 3.

We can look at therapeutic effects. And so one of the first studies that we've conducted looking at therapeutic effects is to look at cancer patients who are experiencing very significant anxiety or fear.

--- Roland Griffiths

These insights could lead to more effective treatments for mood disorders.